Dr. Dagi is a Managing Partner at the Salutramed Group, Inc, a consulting firm that provides analysis and support for critical decision-making for senior life science executives, for foundation and institutional executives and for boards of directors. Read More »
Philip Halpern was elected to the healthEgames Board of Directors in August 2015, after serving as the company’s initial Chief Operating Officer. He has spent most of his career engaged as the Managing Director and/or Chief Investment Officer (CIO) of large institutional portfolios — including for the endowments of The University of Chicago and California Institute of Technology, J.C. Penney Company benefit plans and the Washington State Investment Board pension plan.
R. Wayne Alexander, MD, PhD, is the R. Bruce Logue Professor and immediate past-Chair of the Department of Medicine at Emory University School of Medicine.Read More »
Russell M. Medford,
President & Chief Executive Officer
Russell M. Medford, MD, PhD, is a Managing Partner, Salutramed Group, Inc. and senior biotechnology executive with extensive private and public company experience as Chief Executive Officer and Board member of multiple biotechnology and other health related companies, organizations and research institutes.Read More »
Josh Gottlieb is a practice manager at McKinsey & Company based in Atlanta, GA, focused on building knowledge, solutions, partnerships, and tools with a particular focus on the areas of digital transformation and advanced data & analytics.Read More »
VP of Marketing & Communications
Deborah Halpern has had a distinguished career in marketing and communications. In 2004, she founded DGH Communications a Chicago-based, full-service marketing communications consulting service.Read More »
Dr. Evonne Kaplan-Liss, MD MPH
Responsible for fostering effective communication between HealthEgames and non-medical audiences.Read More »
Margaret K Offermann, MD, PhD Chief Medical Officer
Margaret K Offermann, MD, PhD, is a medical oncologist and biomedical researcher who has extensive senior leadership experience in academic, philanthropic and private healthcare settings and is a Managing Partner at the Salutramed Group, Inc, a life science consulting firm.Read More »
J. Connor Seabrook
Chief Financial Officer
J. Connor Seabrook is a Partner with Alliance Technology Ventures and has worked with several of ATV’s portfolio companies. As Director of Finance & Administration, he helped AtheroGenics during its early stage raise $50 million over five years for R&D and oversaw the construction of its facilities.Read More »
Michael S. Shaw, MD
Chief Product Officer
Dr. Shaw’s background is in medical education, pharmaceutical communications and public health. He began his career as an educational filmmaker and entered medical school at Emory University in order to apply this background to healthcare education. Read More »
VP Technical Operations
Will Macrae is a software engineer at Palantir Technologies, based in Palo Alto, California where he works on building platforms for integrating, managing, and securing data.Read More »
Dr. Johns was recently honored with the 2015 National Physician of the Year Lifetime Achievement Award. He is currently Professor of Medicine and Public Health at Emory University, where he served as Chancellor from 2007 until 2012.Read More »
Louis W. Sullivan, MD
Louis W. Sullivan, M.D., is chairman of the board of the National Health Museum in Atlanta, Georgia, whose goal is to improve the health of Americans by enhancing health literacy and advancing healthy behaviors.Read More »
Gillian M Cannon Ph.D.
Gillian M. Cannon recently transitioned from a very successful career spanning 30 years in the pharmaceutical industry to set up Castle Biotech LLC.Read More »
Michelle Williams is a member of the Firm’s Health Care Practice Group and the Products Liability Practice Group. She is a regulatory attorney with significant experience in the buying and selling of health care companies.
Kenneth I. Moch, of Cognition Therapeutics, Inc., has broad expertise building, managing and financing private and public life science companies from start-up through commercialization, and has helped build five companies which have pioneered novel technologies.
Don W. Bradley, MD, MHS-CL, is an Associate Consulting Professor in the Department of Community and Family Medicine at Duke University School of Medicine and, until his retirement in May 2014, served as Chief Medical Officer and Senior Vice President of Blue Cross and Blue Shield of North Carolina (BCBSNC), a leading health insurance company serving over 3.84 million members.Read More »
Howard Palefsky, Victoria Capital Management, Inc., has extensive experience as an Entrepreneur, CEO, Board Chair, Director and Investor in the life sciences, medical device, healthcare and health and wellness industries.Read More »